Form 4 for IDXX Idexx Laboratories
Accepted 2022-12-05 00:00:00 ET · period of report 2022-12-01 · accession 0001567619-22-021284 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-05 | 2022-12-01 | IDXX | Turner Kathy V | SVP | S - Sale+OE | $436.00 | -3,000 | 6,923 | -30% | -$1.31M |
| D | 2022-12-05 | 2022-12-01 | IDXX | Turner Kathy V | SVP | M - OptEx | $141.60 | +3,000 | 9,923 | +43% | +$424.8K |
| D | 2022-12-05 | 2022-12-01 | IDXX | Turner Kathy V | SVP | M - OptEx | — | -3,000 | 7,386 | -29% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-01 | S | D | 3,000 | $436.00 | 6,923.39 | D | — | — | |
| 2 | Common | Common Stock | 2022-12-01 | M | A | 3,000 | $141.60 | 9,923.39 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2022-12-01 | M | D | 3,000 | — | 7,386 | D | $141.60 · — to 2027-02-13 | 3,000 Common Stock | (F3) Not applicable. (F2) Grant of option to buy 10,386 shares of Issuer common stock that vested in five annual installments beginning on February 14, 2018. |